Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.mtm laboratories raises series c financing round to E31.6 million
mtm plans to use the proceeds of this financing to expand the clinical and commercial development of its p16INK4a based CINtec and Cervatec IVD products. Peter Pack, CEO
mtm plans to use the proceeds of this financing to expand the clinical and commercial development of its p16INK4a based CINtec and Cervatec IVD products. Peter Pack, CEO
The recently completed trial first demonstrated that Sumatriptan powder delivered intranasally using OptiNose’s second generation device has a rapid onset of action and is as effective as subcutaneously
NXD30001 demonstrated efficacy in breast cancer tumor xenograft models without evidence for liver and kidney toxicity. The potency, tolerability, pharmacokinetic and pharmacodynamic properties of NXD30001 and its derivatives
The treatment was found to be safe, with no adverse side effects. It was also shown to have a clear modulatory effect on the immune system. Data demonstrated
ImQuest studies have demonstrated that each of these highly novel pyrimidinedione inhibitors act by two distinct mechanisms of action, preventing the entry of HIV into human cells and
The research conducted at the University of Virginia, showed that mice fed on a heavy fat content diet developed the inflammatory markers for heart disease and diabetes. Mice
Neoprobe intends to enroll approximately 200 patients at up to twenty-five cancer treatment centers in the US and Europe under the amended Phase III clinical protocol. Lymphoseek is
In the study, one of the company’s proprietary Toll-Like Receptor antagonist candidates was evaluated in a mouse model of experimental encephalomyelitis, a preclinical model of multiple sclerosis. Treatment
New investor, New Enterprise Associates (NEA), along with current investors and Alexandria Real Estate Equities, participated in the extension. As part of the financing extension, the company has
The data included results of an analysis of the 11 subdomains of the Alzheimer’s disease Assessment Scale-cognitive subscale (ADAS-cog), a standardized measure of cognition in patients with Alzheimer’s